Proscia Introduces Enhanced Concentriq AP with Multi-AI Workflows for Pathology
A Growing Race to Change Status Quo in the Lucrative NGS Market
FDA Approves Signet Therapeutics' IND Application for sigx1094 in Diffuse Gastric Cancer
Latest